Since CHM had positive effect on CD3 T-lymphocyte, CD4 T-lymphocyte, and CD4+/CD8+ ratio, and reduced TNF-α and mortality, the survival rate may be increased by CHM resulting from the potential immunopharmaceutical effects. This evidence concerns the gene TNF and choroideremia.